Target Name: MIR1284
NCBI ID: G100302112
Review Report on MIR1284 Target / Biomarker Content of Review Report on MIR1284 Target / Biomarker
MIR1284
Other Name(s): hsa-miR-1284 | MIRN1284 | microRNA 1284 | Hsa-mir-1284 | mir-1284 | hsa-mir-1284 | MicroRNA 1284

MIR1284: A Potential Drug Target and Biomarker for Obesity and Related Health Issues

Obesity has become a significant public health concern in recent years due to its increasing prevalence and negative impact on overall health. The number of obesity cases worldwide has increased significantly in adults, children, and adolescents. According to the World Health Organization (WHO), more than 2.3 billion adults are overweight or obese, which accounts for approximately 65% of global population. Obesity has been associated with various health conditions, including cardiovascular diseases, diabetes, and certain cancers. As a result, there is a growing need for effective strategies to treat obesity and its related health issues.

One potential drug target and biomarker that could be useful in addressing obesity is MIR1284. MIR1284 is a protein that is expressed in human tissues and has been shown to play a role in the regulation of energy metabolism and adiposity. MIR1284 has been identified as a potential drug target due to its unique structure and its ability to interact with various signaling pathways.

MIR1284 is a member of the superfamily of G-coupled proteins, which includes proteins that play a critical role in cellular signaling pathways. G-coupled proteins are involved in the regulation of various cellular processes, including cell adhesion, migration, and signaling pathways. MIR1284 is specifically known for its role in the regulation of lipid metabolism and energy homeostasis.

MIR1284 has been shown to interact with several signaling pathways that are involved in obesity and related health issues. One of the most significant interactions of MIR1284 is with the PI3K/Akt signaling pathway. The PI3K/Akt signaling pathway is involved in the regulation of various cellular processes, including inflammation, angiogenesis, and energy metabolism. MIR1284 has been shown to interact with the PI3K/Akt signaling pathway and regulate the activity of the enzyme PIK3CA, which is a key regulator of the PI3K/Akt signaling pathway.

In addition to its interaction with the PI3K/Akt signaling pathway, MIR1284 has also been shown to interact with several other signaling pathways that are involved in obesity and related health issues. For example, MIR1284 has been shown to interact with the Fas signaling pathway, which is involved in the regulation of cell death and survival. MIR1284 has also been shown to interact with the TGF-β signaling pathway, which is involved in the regulation of cell growth and differentiation.

MIR1284 has also been shown to play a role in the regulation of obesity-related behaviors and metrics. For example, MIR1284 has been shown to be involved in the regulation of appetite and satiety, which are critical factors in the development of obesity. In addition, MIR1284 has also been shown to be involved in the regulation of energy metabolism and physical activity, which are also critical factors in the development of obesity.

In conclusion, MIR1284 is a protein that has been identified as a potential drug target due to its unique structure and its ability to interact with various signaling pathways. MIR1284 has been shown to play a role in the regulation of energy metabolism and adiposity, which are key factors in the development of obesity. Further research is needed to determine the full extent of MIR1284's role in obesity and to develop effective strategies for treating obesity and its related health issues.

Protein Name: MicroRNA 1284

The "MIR1284 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1284 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1